Department of Dermatology

Publications 1996-1997

Listed Alphabetically

Research Papers

ANSTEY A, MARKS R, LONG CC, NAVABI H, PEARSE AD, WYNFORD-THOMAS D, JASANI B. In vivo photoinduction of metallothionein in human skin by ultraviolet irradiation. Journal of Pathology 1996, 178:84-88.

BERTH-JONES J, FINLAY AY, ZAKI I, TAN B, GOODYEAR H, LEWIS-JONES M S, CORK M J, BLEEHEN S S, SALEK M S, ALLEN B R, FRIEDMAN P, HARPER P, CAMP R D R, SMITH S, GRAHAM-BROWN R A C. cyclosporin in Severe Childhood Atopic Dermatitis: A Multicentre Study. Journal of the American Academy of Dermatology, 1996, 34, 1016-21.

BICKENBACH, J.R., LONGLEY, M.R., BUNDMAN, D.S., DOMINEY, A.M., BOWDEN, P.E., ROTHNAGEL, J.A. AND ROOP, D.R. (1996). Transgenic Mice Expressing a Mutant Keratin K1 Gene Exhibit Blisters and Hyperkeratosis, Skin Phenotypes Associated With the Human Skin Disease Epidermolytic Hyperkeratosis. Differentiation 61 129-139.

BLACKFORD S, FINLAY A Y, ROBERTS D L. Quality of Life in Behcets Syndrome: 335 Patients Surveyed. British Journal of Dermatology, 1997, 136, 293.

BOWDEN, P.E. (1996). Molecular Biology of Psoriasis and its Future Management. J. Derm. Treatment 7:S1-S6.

CARMICHAEL A J, MOTLEY R J, FINLAY A Y, KENNEDY C T C, WARIN A P. Methotrexate Associated Hepatic Complications and Monitoring Protocols in Dermatology in the United Kingdom. Life Chemistry Reports, 1996, 14, 283-286.

CHAWLA M, ALI M, MARKS R. Comparison of the steady state of pharmacokinetics of two formulations of cyclosporin in patients with atopic dermatitis. Brit J Dermatol, 1996, 135: (suppl 48) 9-14.

DYKES, P J, HILL, S & MARKS, R. Pharmacokinetics of topically applied metronidazole in two different formulations. Skin Pharmacology, 1997, 10, 28-33.

FINLAY A Y. The Outcome Movement and New Measures of Psoriasis. Journal of the American Academy of Dermatology, 1997, 36, 502-503.

FINLAY A Y. Measures of the Effect of Adult Severe Atopic Eczema on Quality of Life. Journal of the European Academy of Dermatology and Venereology, 1996, 7, 149-154.

FINLAY A Y, RYAN T J. Disability and Handicap in Dermatology. International Journal of Dermatology, 1996, 35, 305-311.

FINLAY A Y. Quality of Life - Effects of Chronic Photodamage. Journal of Dermatological Treatment, 1996, 7, Suppl 2, 59-511.

FINLAY A Y. Measurement of Disease Activity and Outcome in Atopic Dermatitis. British Journal of Dermatology, 1996, 135: 509-515.

FINLAY A Y. Clinical Evaluation and Objective Measures of Disease Response. Journal of Dermatological Treatment, 1996, 7 Suppl 3, 517-518.

FINLAY A Y. Quality of Life Measurement in Dermatology: A Practical Guide. British Journal of Dermatology 1997; 136: 305-314.

FINLAY A Y. Emollients as Adjuvant Therapy for Psoriasis. Journal of Dermatological Treatment 1997, 8, 525-527.

FINLAY A Y. Quality of Life and Cost-effectiveness of Treatment. In "Current Management of Psoriasis". Editor: D Gawkrodger. J Derm Treat 1997, 8, 28-29.

HARRIS A, BURGE S M, DYKES P J, FINLAY A Y. Handicap in Darier's Disease and Hailey-Hailey Disease. Br J Derm, 1996, 135, 959-963.

HARVEY I, FRANKEL S, MARKS R, SHALOM D, NOLAN-FARRELL M. Non melanoma skin cancer and solar keratoses. Methods and descriptive results of the South Wales skin cancer study. Br J Cancer 1996; 74: 1302-1307.

HARVEY I, FRANKEL S, MARKS R, SHALOM D, NOLAN-FARRELL M. Non melanoma skin cancer and solar keratoses. Analytical results of the South Wales skin cancer study. Br J Cancer 1996; 74: 1308-1312

JONES D.O, WATTS C.E., MILLS C.M., SHARPE, G., MARKS R, BOWDEN P.E. (1997). A New Keratin 2e Mutation in Ichthyosis Bullosa of Siemens. J. Invest. Dermatol. 108 (3) 354-356.

LONG C C, FINLAY A Y. Area of Skin Disease can be used to indicate amount of treatment needed. BMJ, 1996, 313, 690.

LONG C C, FINLAY A Y. Linear Lichen Planus in the Lines of Blaschko. Br J Dermatol, 1996, 135, 275-276.

LONG CC, MARKS R. The response to ultraviolet radiation and delayed hypersensitivity in Celts with skin cancer. J Eur Acad Derm & Venereol 1996, 6: 20-26

LONG C C, TURNER R J, MARKS R.. Actinic Keratoses: the bald facts. Arch Dermatol 1996; 132: 1132-1133.

LU H, EDWARDS C, GASKELL S, PEARSE A, MARKS R. Melanin content and distribution in the surface corneocyte with skin phototypes. Br. J. Dermatol 1996; 135: 263-267 .

MARKS, R, BOWDEN, P.E. Die Ichthyosen: Neue Informationen und Klassifikation. Dermatologie 1996, 38 188-191.

MARKS R. Early clinical development of Tazarotene. Brit J Dermatol 1996; 135: (suppl 49), 26-31.

MILLS C M, HILL S A, MARKS R. Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol 1997, 133: 823-825.

TANAKA M, DYKES PJ, MARKS R. Keratinocyte growth stimulation by granulocyte-macrophage colony-stimulating factor (GM-CSF). Keio J Med 1997, 46(4): 184-187.

THOMAS RC, EDWARDS MJ, MARKS R. Translocation of the retinoblastoma gene product during mitosis. Exp Cell Res 1996, 223: 227 - 232.

WONG SS, EDWARDS C, MARKS R. A study of white dermographism in atopic dermatitis. J. Dermatol Sci. 1996; 11: 148-153.

Back to publications list